Mimesis Law Podcast

Merck Targets Gilead Over Hep-C Treatment | Markman Minute

Informações:

Sinopse

February 23, 2016 (Mimesis Law) - Gaston and Lee sit down to discuss the coming trial between Merck and Gilead Pharmaceuticals over Gilead's almost miraculous Hepatitis-C treatment. Mimesis’ Markman Minute | Intellectual Property & Patent Litigation Intellectual property attorney, consultant and blogger Gaston Kroub takes a deeper look at some of the biggest current patent stories of interest to investors. Subscribe to his daily posts at MimesisLaw.com. You can follow him on Twitter: @MarkmanAdvisors Mimesis Law covers the business, practice and culture of law. Mimesis Labs partners with companies and organizations to design, create and leverage video content. Lee Pacchia is the Founder and CEO.